Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Hawkey

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
JAMA|August 30, 2008
Guest authorship, mortality reporting, and integrity in rofecoxib studiesChristopher J Hawkey
Best Practice & Research. Clinical Haematology|August 11, 2004
Stem cell transplantation for Crohn's diseaseChristopher J Hawkey
Lancet (London, England)|December 19, 2008
Assessing bleeds clinically: what's the score?Venkataraman Subramanian, Christopher J Hawkey
British Journal of Clinical Pharmacology|August 5, 2003
Assessment of non-steroidal anti-inflammatory drug (NSAID) damage in the human gastrointestinal tractMartin W James, Christopher J Hawkey
Gastroenterology|November 16, 2016
Is Stem Cell Therapy Ready for Prime Time in Treatment of Inflammatory Bowel Diseases?Christopher J Hawkey, Daniel W Hommes
Current Opinion in Gastroenterology|October 13, 2005
Cyclooxygenase-2 inhibitorsChristopher J Hawkey, Paul J Fortun
Current Opinion in Gastroenterology|February 3, 2007
Nonsteroidal antiinflammatory drugs and the small intestinePaul J Fortun, Christopher J Hawkey
JAMA|June 22, 2016
Stem Cell Transplantation for Refractory Crohn Disease--ReplyChristopher J Hawkey, James Lindsay, John Gribben
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 7, 2011
Ratio of visceral to subcutaneous fat area is a biomarker of complicated Crohn's diseaseBara Erhayiem, Rajpal Dhingsa, Christopher J Hawkey, et al.
BMJ Open|September 13, 2017
Living with Crohn's disease: an exploratory cross-sectional qualitative study into decision-making and expectations in relation to autologous haematopoietic stem cell treatment (the DECIDES study)Joanne Cooper, Iszara Blake, James O Lindsay, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
JAMA|August 30, 2008
Guest authorship, mortality reporting, and integrity in rofecoxib studiesChristopher J Hawkey
Best Practice & Research. Clinical Haematology|August 11, 2004
Stem cell transplantation for Crohn's diseaseChristopher J Hawkey
Lancet (London, England)|December 19, 2008
Assessing bleeds clinically: what's the score?Venkataraman Subramanian, Christopher J Hawkey
British Journal of Clinical Pharmacology|August 5, 2003
Assessment of non-steroidal anti-inflammatory drug (NSAID) damage in the human gastrointestinal tractMartin W James, Christopher J Hawkey
Gastroenterology|November 16, 2016
Is Stem Cell Therapy Ready for Prime Time in Treatment of Inflammatory Bowel Diseases?Christopher J Hawkey, Daniel W Hommes
Current Opinion in Gastroenterology|October 13, 2005
Cyclooxygenase-2 inhibitorsChristopher J Hawkey, Paul J Fortun
Current Opinion in Gastroenterology|February 3, 2007
Nonsteroidal antiinflammatory drugs and the small intestinePaul J Fortun, Christopher J Hawkey
JAMA|June 22, 2016
Stem Cell Transplantation for Refractory Crohn Disease--ReplyChristopher J Hawkey, James Lindsay, John Gribben
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 7, 2011
Ratio of visceral to subcutaneous fat area is a biomarker of complicated Crohn's diseaseBara Erhayiem, Rajpal Dhingsa, Christopher J Hawkey, et al.
BMJ Open|September 13, 2017
Living with Crohn's disease: an exploratory cross-sectional qualitative study into decision-making and expectations in relation to autologous haematopoietic stem cell treatment (the DECIDES study)Joanne Cooper, Iszara Blake, James O Lindsay, et al.
Pageof 5